Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Dolby Laboratories, Inc. (DLB)

Compare
80.63
+0.32
+(0.40%)
At close: 4:00:02 PM EDT
80.63
0.00
(0.00%)
After hours: 6:05:58 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 357M
Earnings --

Q1'24

Q2'24

Q3'24

Q4'24

0
100M
200M
300M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

100.00
100.00 Average
80.63 Current
100.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2233
Avg. Estimate 1.280.774.074.38
Low Estimate 1.260.754.024.34
High Estimate 1.30.794.14.46
Year Ago EPS 1.270.713.794.07

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2222
Avg. Estimate 375.44M302.96M1.35B1.43B
Low Estimate 371.67M299.77M1.35B1.41B
High Estimate 379.21M306.15M1.36B1.44B
Year Ago Sales 364.52M288.82M1.27B1.35B
Sales Growth (year/est) 2.99%4.90%6.25%5.58%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 1.190.590.70.98
EPS Actual 1.270.710.811.14
Difference 0.080.120.110.16
Surprise % 6.42%20.34%16.27%16.72%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 1.280.774.074.38
7 Days Ago 1.280.774.074.38
30 Days Ago 1.280.774.074.38
60 Days Ago 1.260.773.974.4
90 Days Ago 1.360.84.064.34

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --111
Up Last 30 Days --111
Down Last 7 Days 111--
Down Last 30 Days 111--

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
DLB 0.79%8.45%7.39%7.70%
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Maintains Barrington Research: Outperform to Outperform 2/13/2025
Maintains Barrington Research: Outperform to Outperform 1/30/2025
Maintains Rosenblatt: Buy to Buy 1/30/2025
Maintains Barrington Research: Outperform to Outperform 1/27/2025
Maintains Rosenblatt: Buy to Buy 1/23/2025
Maintains Barrington Research: Outperform to Outperform 11/20/2024

Related Tickers